Literature DB >> 24066888

Structural vaccinology: a three-dimensional view for vaccine development.

Roberta Cozzi1, Maria Scarselli, Ilaria Ferlenghi.   

Abstract

The Structural Vaccinology (SV) approach is the logical evolution of Reverse Vaccinology: a genome-based approach combined with structural biology, with the idea that protective determinants can be used to selectively engineer the antigens that can be re-designed and simplified for inclusion in vaccine combinations. The final objectives of the rational structure-based antigen optimization are the facilitation of industrial-scale production of the antigens combination, obtain a greater immunogenicity and a greater safety profile and finally expand the breadth of protection. Structural Vaccinology is particularly powerful in case of antigenic variation between closely related strains and species. Several examples are available in literature of how SV has already been applied successfully to several bacterial and viral projects. The examples of structure-based antigens optimization reviewed here describe different template procedures that can be followed to develop improved vaccines against other pathogens and potentially help resolve challenges in manufacturing or efficacy.

Mesh:

Substances:

Year:  2013        PMID: 24066888     DOI: 10.2174/15680266113136660187

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  14 in total

1.  The promise and challenge of epitope-focused vaccines.

Authors:  Jon Oscherwitz
Journal:  Hum Vaccin Immunother       Date:  2016-04-08       Impact factor: 3.452

Review 2.  Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets.

Authors:  R Servín-Blanco; R Zamora-Alvarado; G Gevorkian; K Manoutcharian
Journal:  Hum Vaccin Immunother       Date:  2016-06-13       Impact factor: 3.452

3.  Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form.

Authors:  Joyce J W Wong; Reay G Paterson; Robert A Lamb; Theodore S Jardetzky
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-28       Impact factor: 11.205

Review 4.  Protein Crystallography in Vaccine Research and Development.

Authors:  Enrico Malito; Andrea Carfi; Matthew J Bottomley
Journal:  Int J Mol Sci       Date:  2015-06-09       Impact factor: 5.923

5.  MEFA (multiepitope fusion antigen)-Novel Technology for Structural Vaccinology, Proof from Computational and Empirical Immunogenicity Characterization of an Enterotoxigenic Escherichia coli (ETEC) Adhesin MEFA.

Authors:  Qiangde Duan; Kuo Hao Lee; Rahul M Nandre; Carolina Garcia; Jianhan Chen; Weiping Zhang
Journal:  J Vaccines Vaccin       Date:  2017-08-24

6.  Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibody.

Authors:  Paola Favuzza; Elena Guffart; Marco Tamborrini; Bianca Scherer; Anita M Dreyer; Arne C Rufer; Johannes Erny; Joerg Hoernschemeyer; Ralf Thoma; Georg Schmid; Bernard Gsell; Araceli Lamelas; Joerg Benz; Catherine Joseph; Hugues Matile; Gerd Pluschke; Markus G Rudolph
Journal:  Elife       Date:  2017-02-14       Impact factor: 8.140

Review 7.  Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens.

Authors:  Lassi Liljeroos; Enrico Malito; Ilaria Ferlenghi; Matthew James Bottomley
Journal:  J Immunol Res       Date:  2015-10-07       Impact factor: 4.818

Review 8.  Towards developing a vaccine for rheumatic heart disease.

Authors:  Geethanjali Devadoss Gandhi; Navaneethakrishnan Krishnamoorthy; Ussama M Abdel Motal; Magdi Yacoub
Journal:  Glob Cardiol Sci Pract       Date:  2017-03-31

Review 9.  Postgenomic Approaches and Bioinformatics Tools to Advance the Development of Vaccines against Bacteria of the Burkholderia cepacia Complex.

Authors:  Sílvia A Sousa; António M M Seixas; Jorge H Leitão
Journal:  Vaccines (Basel)       Date:  2018-06-08

10.  An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.

Authors:  Dhiraj Acharya; Fengwei Bai
Journal:  Methods Mol Biol       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.